20 June 2013
Keywords: skyepharma, looking, paxil, profitability, uk, hoping, turn
Article | 04 September 1998
SkyePharma of the UK is hoping to turn cash positive next year, mainlydue to the forthcoming commercialization of its controlled-release
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 1998
2 September 1998
19 June 2013
© 2013 thepharmaletter.com